These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

593 related items for PubMed ID: 21075605

  • 41. The outcome of treating ESBL infections with carbapenems vs. non carbapenem antimicrobials.
    Trivedi M, Patel V, Soman R, Rodriguez C, Singhal T.
    J Assoc Physicians India; 2012 Aug; 60():28-30. PubMed ID: 23405518
    [Abstract] [Full Text] [Related]

  • 42. Extended-spectrum beta-lactamase-producing organisms.
    Falagas ME, Karageorgopoulos DE.
    J Hosp Infect; 2009 Dec; 73(4):345-54. PubMed ID: 19596491
    [Abstract] [Full Text] [Related]

  • 43. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
    Peirano G, Costello M, Pitout JD.
    Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
    [Abstract] [Full Text] [Related]

  • 44. Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome.
    Kim SH, Kwon JC, Choi SM, Lee DG, Park SH, Choi JH, Yoo JH, Cho BS, Eom KS, Kim YJ, Kim HJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS.
    Ann Hematol; 2013 Apr; 92(4):533-41. PubMed ID: 23161391
    [Abstract] [Full Text] [Related]

  • 45. Emergence of SHV-12 extended spectrum beta-lactamase among clinical isolates of Enterobacter cloacae in Tunisia.
    Lahlaoui H, Anis BH, Mohamed K, Mohamed BM.
    Microb Pathog; 2012 Aug; 53(2):64-5. PubMed ID: 22543154
    [Abstract] [Full Text] [Related]

  • 46. Cefepime Therapy for Monomicrobial Enterobacter cloacae Bacteremia: Unfavorable Outcomes in Patients Infected by Cefepime-Susceptible Dose-Dependent Isolates.
    Lee NY, Lee CC, Li CW, Li MC, Chen PL, Chang CM, Ko WC.
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7558-63. PubMed ID: 26416853
    [Abstract] [Full Text] [Related]

  • 47. Prevalence and diversity of qnr alleles in AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii and Serratia marcescens: a multicentre study from Korea.
    Park YJ, Yu JK, Lee S, Oh EJ, Woo GJ.
    J Antimicrob Chemother; 2007 Oct; 60(4):868-71. PubMed ID: 17660263
    [Abstract] [Full Text] [Related]

  • 48. Enteric gram-negative bacilli bloodstream infections: 17 years' experience in a neonatal intensive care unit.
    Cordero L, Rau R, Taylor D, Ayers LW.
    Am J Infect Control; 2004 Jun; 32(4):189-95. PubMed ID: 15175611
    [Abstract] [Full Text] [Related]

  • 49. [Recent evolution and characterization of extended-spectrum beta-lactamase producing enterobacteria in the CHU of Nice (2005-2007)].
    Giraud-Morin C, Fosse T.
    Pathol Biol (Paris); 2008 Jun; 56(7-8):417-23. PubMed ID: 18848404
    [Abstract] [Full Text] [Related]

  • 50. Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases.
    Endimiani A, Luzzaro F, Brigante G, Perilli M, Lombardi G, Amicosante G, Rossolini GM, Toniolo A.
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2598-605. PubMed ID: 15980325
    [Abstract] [Full Text] [Related]

  • 51. Risk factor analysis for extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections in central Taiwan.
    Chen CH, Huang CC.
    BMC Infect Dis; 2013 Sep 08; 13():417. PubMed ID: 24010678
    [Abstract] [Full Text] [Related]

  • 52. Monoclonal outbreak of VIM-1-carbapenemase-producing Enterobacter cloacae in intensive care unit, University Hospital Centre Split, Croatia.
    Novak A, Goic-Barisic I, Andrasevic AT, Butic I, Radic M, Jelic M, Rubic Z, Tonkic M.
    Microb Drug Resist; 2014 Oct 08; 20(5):399-403. PubMed ID: 24716493
    [Abstract] [Full Text] [Related]

  • 53. Outbreak of catheter-associated Klebsiella oxytoca and Enterobacter cloacae bloodstream infections in an oncology chemotherapy center.
    Watson JT, Jones RC, Siston AM, Fernandez JR, Martin K, Beck E, Sokalski S, Jensen BJ, Arduino MJ, Srinivasan A, Gerber SI.
    Arch Intern Med; 2014 Oct 08; 165(22):2639-43. PubMed ID: 16344422
    [Abstract] [Full Text] [Related]

  • 54. Characterisation and clinical features of Enterobacter cloacae bloodstream infections occurring at a tertiary care university hospital in Switzerland: is cefepime adequate therapy?
    Hilty M, Sendi P, Seiffert SN, Droz S, Perreten V, Hujer AM, Bonomo RA, Mühlemann K, Endimiani A.
    Int J Antimicrob Agents; 2013 Mar 08; 41(3):236-49. PubMed ID: 23313399
    [Abstract] [Full Text] [Related]

  • 55. Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children.
    Zaoutis TE, Goyal M, Chu JH, Coffin SE, Bell LM, Nachamkin I, McGowan KL, Bilker WB, Lautenbach E.
    Pediatrics; 2005 Apr 08; 115(4):942-9. PubMed ID: 15805368
    [Abstract] [Full Text] [Related]

  • 56. Outbreak of multidrug-resistant CTX-M-15-producing Enterobacter cloacae in a neonatal intensive care unit.
    Oteo J, Cercenado E, Vindel A, Bautista V, Fernández-Romero S, Saéz D, Padilla B, Zamora E, Campos J.
    J Med Microbiol; 2013 Apr 08; 62(Pt 4):571-575. PubMed ID: 23264454
    [Abstract] [Full Text] [Related]

  • 57. Dissemination of multiresistant Enterobacter cloacae isolates producing OXA-48 and CTX-M-15 in a Spanish hospital.
    Fernández J, Montero I, Martínez Ó, Fleites A, Poirel L, Nordmann P, Rodicio MR.
    Int J Antimicrob Agents; 2015 Oct 08; 46(4):469-74. PubMed ID: 26307466
    [Abstract] [Full Text] [Related]

  • 58. Molecular typing and characterization of TEM, SHV, CTX-M, and CMY-2 β-lactamases in Enterobacter cloacae strains isolated in patients and their hospital environment in the west of Algeria.
    Souna D, Amir AS, Bekhoucha SN, Berrazeg M, Drissi M.
    Med Mal Infect; 2014 Apr 08; 44(4):146-52. PubMed ID: 24731757
    [Abstract] [Full Text] [Related]

  • 59. Orally administered colistin leads to colistin-resistant intestinal flora and fails to prevent faecal colonisation with extended-spectrum β-lactamase-producing enterobacteria in hospitalised newborns.
    Strenger V, Gschliesser T, Grisold A, Zarfel G, Feierl G, Masoud L, Hoenigl M, Resch B, Müller W, Urlesberger B.
    Int J Antimicrob Agents; 2011 Jan 08; 37(1):67-9. PubMed ID: 21074372
    [Abstract] [Full Text] [Related]

  • 60. Molecular epidemiology of CTX-M producing Enterobacteriaceae isolated from bloodstream infections in Rio de Janeiro, Brazil: emergence of CTX-M-15.
    Seki LM, Pereira PS, de Souza Conceição M, Souza MJ, Marques EA, Carballido JM, de Carvalho ME, Assef AP, Asensi MD.
    Braz J Infect Dis; 2013 Jan 08; 17(6):640-6. PubMed ID: 24055309
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.